Finally, Touil et al. have documented increased YAP protein levels in response to 5-FU or oxaliplatin, which has to be brought together with the increased levels of YAP1 mRNA in liver metastases from chemotherapy-treated versus untreated CRC patients [19]. The gene discussed is YAP1; the disease is colorectal carcinoma.